{"parse":{"title":"Louis Preston Garrison","pageid":55534101,"revid":825175475,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox biography vcard\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold\"><span class=\"honorific-prefix\" style=\"font-size: 77%; font-weight: normal;\"><a href=\"/wiki/Emeritus\" title=\"Emeritus\">Emeritus</a></span><br /><span class=\"fn\">Louis P. Garrison, Jr.</span></th></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n<a href=\"/wiki/File:Garrison_portrait_1.png\" class=\"image\"><img alt=\"Garrison portrait 1.png\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/e/eb/Garrison_portrait_1.png/220px-Garrison_portrait_1.png\" width=\"220\" height=\"346\" srcset=\"//upload.wikimedia.org/wikipedia/commons/e/eb/Garrison_portrait_1.png 1.5x\" data-file-width=\"273\" data-file-height=\"429\" /></a></td></tr><tr><th scope=\"row\">Born</th><td>\n1950<br /><span class=\"birthplace\"><a href=\"/wiki/Indiana\" title=\"Indiana\">Indiana</a>, USA</span></td></tr><tr><th scope=\"row\">Citizenship</th><td class=\"category\">\n<a href=\"/wiki/United_States_of_America\" class=\"mw-redirect\" title=\"United States of America\">United States of America</a></td></tr><tr><td colspan=\"2\" style=\"text-align:center\">\n</td></tr><tr><th scope=\"row\">Institution</th><td>\n<a href=\"/wiki/University_of_Washington\" title=\"University of Washington\">University of Washington</a></td></tr><tr><th scope=\"row\">Field</th><td class=\"category\">\n<a href=\"/wiki/Health_economics\" title=\"Health economics\">health economics</a></td></tr><tr><th scope=\"row\">Alma&#160;mater</th><td>\n<a href=\"/wiki/Stanford_University\" title=\"Stanford University\">Stanford University</a> (Ph.D.)<br /><a href=\"/wiki/Indiana_University\" title=\"Indiana University\">Indiana University</a> (B.S.)</td></tr><tr><th scope=\"row\">Doctoral<br />advisor</th><td>\n<a href=\"/wiki/Victor_Fuchs\" title=\"Victor Fuchs\">Victor Fuchs</a></td></tr><tr><th scope=\"row\">Influences</th><td>\n<a href=\"/wiki/Pharmacoeconomics\" title=\"Pharmacoeconomics\">Pharmacoeconomics</a></td></tr><tr style=\"display:none\"><td colspan=\"2\">\n</td></tr><tr><th scope=\"row\">Website</th><td>\n<span class=\"url\"><a rel=\"nofollow\" class=\"external text\" href=\"https://sop.washington.edu/people/louis-garrison/\">sop<wbr />.washington<wbr />.edu<wbr />/people<wbr />/louis-garrison<wbr />/</a></span></td></tr></tbody></table>\n<p><b>Louis Preston Garrison Jr.</b> (born 1950) is an American <a href=\"/wiki/Health_economist\" class=\"mw-redirect\" title=\"Health economist\">health economist</a> who has made significant contributions to <a href=\"/wiki/Pharmacoeconomics\" title=\"Pharmacoeconomics\">pharmacoeconomics</a>, <a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">pharmacogenomics</a> and <a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">personalized medicine</a>, regulatory benefit-risk analysis, <a href=\"/wiki/Insurance\" title=\"Insurance\">insurance</a>, <a href=\"/wiki/Pricing\" title=\"Pricing\">pricing</a>, <a href=\"/wiki/Reimbursement\" title=\"Reimbursement\">reimbursement</a> and risk-sharing agreements. He also made numerous contributions on the economic evaluation of pharmaceuticals, diagnostics, devices, surgical procedures, and vaccines, particularly as related to organ transplantation, influenza, measles, obesity, and cancer. Garrison has published over a hundred manuscripts in peer-reviewed journals and contributed to several book chapters.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Education\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Education</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Career\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Career</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Incentives_to_pharmaceutical_innovation\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Incentives to pharmaceutical innovation</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Value_of_personalized_medicine\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Value of personalized medicine</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Risk_sharing_agreements\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Risk sharing agreements</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#Awards_and_recognition\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Awards and recognition</span></a></li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Legacy\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">Legacy</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Education\">Education</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=1\" title=\"Edit section: Education\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Garrison received his <a href=\"/wiki/B.A.\" class=\"mw-redirect\" title=\"B.A.\">B.A.</a> in Economics at <a href=\"/wiki/Indiana_University\" title=\"Indiana University\">Indiana University</a> and his <a href=\"/wiki/Ph.D.\" class=\"mw-redirect\" title=\"Ph.D.\">Ph.D.</a> in Economics at <a href=\"/wiki/Stanford_University\" title=\"Stanford University\">Stanford University</a>. During his doctoral training, Garrison was mentored by <a href=\"/wiki/Victor_Fuchs\" title=\"Victor Fuchs\">Victor Fuchs</a>, who was considered \"the dean of health economists.\"<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Career\">Career</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=2\" title=\"Edit section: Career\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Garrison served as the president of the International Society for Pharmacoeconomics and Outcomes Research (2016-2017) and is <a href=\"/wiki/Professor_Emeritus\" class=\"mw-redirect\" title=\"Professor Emeritus\">Professor Emeritus</a> at the <a href=\"/wiki/University_of_Washington_School_of_Pharmacy\" title=\"University of Washington School of Pharmacy\">University of Washington School of Pharmacy</a>. Garrison\u2019s career began with 13 years in non-profit health policy research at the <a href=\"/wiki/Battelle_Memorial_Institute\" title=\"Battelle Memorial Institute\">Battelle Memorial Institute</a> Human Affairs Research Centers (Seattle), and at the <a href=\"/wiki/Project_HOPE\" title=\"Project HOPE\">Project HOPE</a> Center for Health Affairs (Virginia), where he was the Director from 1989-1992. Following this, he worked as an economist in the pharmaceutical industry for 12 years. From 2002-2004, he was Vice President and Head of Health Economics &amp; Strategic Pricing in <a href=\"/wiki/Hoffmann-La_Roche\" title=\"Hoffmann-La Roche\">Hoffmann-La Roche</a> Pharmaceuticals, and was based in Basel, Switzerland. He then joined the faculty at the <a href=\"/wiki/University_of_Washington_School_of_Pharmacy\" title=\"University of Washington School of Pharmacy\">University of Washington School of Pharmacy</a> in 2004 until his retirement in 2017.\n</p>\n<h2><span class=\"mw-headline\" id=\"Incentives_to_pharmaceutical_innovation\">Incentives to pharmaceutical innovation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=3\" title=\"Edit section: Incentives to pharmaceutical innovation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Garrison argued that a major challenge to pharmaceutical innovation has been the misalignment of incentives.<sup id=\"cite_ref-Oncology_2-0\" class=\"reference\"><a href=\"#cite_note-Oncology-2\">&#91;2&#93;</a></sup> He further argued that the global product life cycle of oncology medications depended in large part to monopoly power associated with time-limited patent protection given by the <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a>. Garrison highlighted that value is a dynamic and moving target and that pharmaceutical pricing should reward innovation based on the value created. Inflexible or fixed pricing schemes do not capture the dynamic value of pharmaceuticals, especially when considering the product life cycle. Moreover, Garrison argued that value creation through value capture would promote public goods through private markets with appropriate patent protection.\n</p>\n<h2><span class=\"mw-headline\" id=\"Value_of_personalized_medicine\">Value of personalized medicine</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=4\" title=\"Edit section: Value of personalized medicine\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The advent of personalized medicine prompted discussion on its value and reimbursement decision. Garrison and <a href=\"/w/index.php?title=MJ_Finley_Austin&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MJ Finley Austin (page does not exist)\">MJ Finley Austin</a> used a standard insure-payer reimbursement framework to identify that health systems reforms are necessary to develop economic incentives for personalized medicine.<sup id=\"cite_ref-PersonMedicine_3-0\" class=\"reference\"><a href=\"#cite_note-PersonMedicine-3\">&#91;3&#93;</a></sup> Additionally, Garrison and <a href=\"/w/index.php?title=Adrian_Towse&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Adrian Towse (page does not exist)\">Adrian Towse</a> argued that reimbursement for innovative, patent-protected diagnostic and therapeutic products needs to be value-based and flexible.<sup id=\"cite_ref-Garrison_Towse_4-0\" class=\"reference\"><a href=\"#cite_note-Garrison_Towse-4\">&#91;4&#93;</a></sup> Garrison believed that a global perspective is necessary to share the cost of innovative medicines, which will result in dynamic efficiency and global public goods; and further argued that the high-cost of personalized medicine requires society to share the costs through efficient pricing and reimbursement strategies.\n</p>\n<h2><span class=\"mw-headline\" id=\"Risk_sharing_agreements\">Risk sharing agreements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=5\" title=\"Edit section: Risk sharing agreements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Garrison also evaluated the use of Risk Sharing Agreements (RSA) between pharmaceutical companies and health care payers. RSAs are contracts between pharmaceutical companies and health care payers that link coverage reimbursement to pharmaceutical performance.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> Performance can be defined as financial-based and outcomes-based. Financial-based RSA has reimbursements tied to the market share and utilization of pharmaceutical. Whereas, outcomes-based RSA has reimbursements based on the drug's clinical/health outcomes. Garrison and colleagues reported that US health care payers expressed interest in financial-based RSA but were reluctant to implement outcomes-based RSA due to a lack of confidence.<sup id=\"cite_ref-RSA_6-0\" class=\"reference\"><a href=\"#cite_note-RSA-6\">&#91;6&#93;</a></sup> These barriers would need to be addressed before any nation-wide RSA takes place between pharmaceutical companies and health care payers.\n</p>\n<h2><span class=\"mw-headline\" id=\"Awards_and_recognition\">Awards and recognition</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=6\" title=\"Edit section: Awards and recognition\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 2017, Garrison was selected as part of the PharmVOICE 100.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> Garrison was also honored by being inducted to New Albany High School Hall of Fame (2017),<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> and being honored for his life-time achievements at the Pharmaceutical Outcomes Research and Policy Program 20th Anniversary Research Symposium hosted by University of Washington School of Pharmacy (2016).\n</p>\n<h2><span class=\"mw-headline\" id=\"Legacy\">Legacy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=7\" title=\"Edit section: Legacy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Garrison and his wife established several funds at the University of Washington: the Garrison Family Fund for Global Health Economics Education, the Louis Sr. and Marilyn Garrison Endowed Prize in Health Policy and Economics; and the Penny Evans Fund for the University of Washington International Society for Pharmacoeconomics and Outcomes Research Student Chapter.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Louis_Preston_Garrison&amp;action=edit&amp;section=8\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Leonhardt, David (25 August 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nytimes.com/2009/08/26/business/economy/26leonhardt.html\">\"Real Choice? It's Off Limits in Health Bills\"</a>. <i>The New York Times</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Real+Choice%3F+It%E2%80%99s+Off+Limits+in+Health+Bills&amp;rft.date=2009-08-25&amp;rft.aulast=Leonhardt&amp;rft.aufirst=David&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F08%2F26%2Fbusiness%2Feconomy%2F26leonhardt.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Oncology-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Oncology_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garrison, Louis P. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://theoncologist.alphamedpress.org/content/15/suppl_1/49.short\">\"Rewarding Value Creation to Promote Innovation in Oncology:The Importance of Considering the Global Product Life Cycle\"</a>. <i>The Oncologist</i>. <b>15</b> (suppl 1): 49\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1634/theoncologist.2010-S1-49\">10.1634/theoncologist.2010-S1-49</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Oncologist&amp;rft.atitle=Rewarding+Value+Creation+to+Promote+Innovation+in+Oncology%3AThe+Importance+of+Considering+the+Global+Product+Life+Cycle&amp;rft.volume=15&amp;rft.issue=suppl+1&amp;rft.pages=49-57&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.2010-S1-49&amp;rft.aulast=Garrison&amp;rft.aufirst=Louis+P.&amp;rft_id=http%3A%2F%2Ftheoncologist.alphamedpress.org%2Fcontent%2F15%2Fsuppl_1%2F49.short&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-PersonMedicine-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-PersonMedicine_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garrison, Louis P.; Austin, MJ Finley (2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://journals.sagepub.com/doi/abs/10.1177/009286150704100408\">\"The Economics of Personalized Medicine: A Model of Incentives for Value Creation and Capture\"</a>. <i><a href=\"/wiki/Therapeutic_Innovation_%26_Regulatory_Science\" title=\"Therapeutic Innovation &amp; Regulatory Science\">Therapeutic Innovation &amp; Regulatory Science</a></i>. <b>41</b> (4): 501\u2013509. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/009286150704100408\">10.1177/009286150704100408</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Innovation+%26+Regulatory+Science&amp;rft.atitle=The+Economics+of+Personalized+Medicine%3A+A+Model+of+Incentives+for+Value+Creation+and+Capture&amp;rft.volume=41&amp;rft.issue=4&amp;rft.pages=501-509&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1177%2F009286150704100408&amp;rft.aulast=Garrison&amp;rft.aufirst=Louis+P.&amp;rft.au=Austin%2C+MJ+Finley&amp;rft_id=http%3A%2F%2Fjournals.sagepub.com%2Fdoi%2Fabs%2F10.1177%2F009286150704100408&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Garrison_Towse-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Garrison_Towse_4-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garrison, Louis P.; Towse, Adrian (2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.mdpi.com/2075-4426/7/3/10\">\"Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics\"</a>. <i>Journal of Personalized Medicine</i>. <b>7</b> (10): 1\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/jpm7030010\">10.3390/jpm7030010</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Personalized+Medicine&amp;rft.atitle=Value-Based+Pricing+and+Reimbursement+in+Personalised+Healthcare%3A+Introduction+to+the+Basic+Health+Economics&amp;rft.volume=7&amp;rft.issue=10&amp;rft.pages=1-10&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.3390%2Fjpm7030010&amp;rft.aulast=Garrison&amp;rft.aufirst=Louis+P.&amp;rft.au=Towse%2C+Adrian&amp;rft_id=http%3A%2F%2Fwww.mdpi.com%2F2075-4426%2F7%2F3%2F10&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cook, Joseph P.; Vernon, John A.; Manning, Richard (2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://link.springer.com/article/10.2165/00019053-200826070-00002\">\"Pharmaceutical risk-sharing agreements\"</a>. <i><a href=\"/wiki/PharmacoEconomics\" class=\"mw-redirect\" title=\"PharmacoEconomics\">PharmacoEconomics</a></i>. <b>26</b> (7): 551\u20136. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18563946\">18563946</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PharmacoEconomics&amp;rft.atitle=Pharmaceutical+risk-sharing+agreements&amp;rft.volume=26&amp;rft.issue=7&amp;rft.pages=551-6&amp;rft.date=2008&amp;rft_id=info%3Apmid%2F18563946&amp;rft.aulast=Cook&amp;rft.aufirst=Joseph+P.&amp;rft.au=Vernon%2C+John+A.&amp;rft.au=Manning%2C+Richard&amp;rft_id=https%3A%2F%2Flink.springer.com%2Farticle%2F10.2165%2F00019053-200826070-00002&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-RSA-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-RSA_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Garrison, Louis P.; Carlson, Josh; Bajaj, Preeti; Towse, Adrian; Neumann, Peter; Sullivan, Sean; Westrich, Kimberly; Dubois, Robert (2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ajmc.com/journals/issue/2015/2015-vol21-n9/Private-Sector-Risk-Sharing-Agreements-in-the-United-States-Trends-Barriers-and-Prospects\">\"Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects\"</a>. <i><a href=\"/wiki/The_American_Journal_of_Managed_Care\" title=\"The American Journal of Managed Care\">The American Journal of Managed Care</a></i>. <b>21</b> (21): 632\u2013640. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26618366\">26618366</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Managed+Care&amp;rft.atitle=Private+Sector+Risk-Sharing+Agreements+in+the+United+States%3A+Trends%2C+Barriers%2C+and+Prospects&amp;rft.volume=21&amp;rft.issue=21&amp;rft.pages=632-640&amp;rft.date=2015&amp;rft_id=info%3Apmid%2F26618366&amp;rft.aulast=Garrison&amp;rft.aufirst=Louis+P.&amp;rft.au=Carlson%2C+Josh&amp;rft.au=Bajaj%2C+Preeti&amp;rft.au=Towse%2C+Adrian&amp;rft.au=Neumann%2C+Peter&amp;rft.au=Sullivan%2C+Sean&amp;rft.au=Westrich%2C+Kimberly&amp;rft.au=Dubois%2C+Robert&amp;rft_id=http%3A%2F%2Fwww.ajmc.com%2Fjournals%2Fissue%2F2015%2F2015-vol21-n9%2FPrivate-Sector-Risk-Sharing-Agreements-in-the-United-States-Trends-Barriers-and-Prospects&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.pharmavoice.com/current-100/\">\"PharmaVOICE 100 \u2014 Class of 2017\"</a>. PharmVOICE<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">October 13,</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PharmaVOICE+100+%E2%80%94+Class+of+2017&amp;rft.pub=PharmVOICE&amp;rft_id=http%3A%2F%2Fwww.pharmavoice.com%2Fcurrent-100%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ALouis+Preston+Garrison\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"> <a rel=\"nofollow\" class=\"external text\" href=\"http://www.newsandtribune.com/news/new-albany-high-school-hall-of-fame-class-announced/article_86c754e2-59f1-11e7-ac0f-27906ccb99f3.html\">\"New Albany High School Hall of Fame class announced\"</a>, <i><a href=\"/wiki/News_and_Tribune\" title=\"News and Tribune\">News and Tribune</a></i>, New Albany, 25 June 2017. Retrieved on 13 October 2017.</span>\n</li>\n</ol></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q44230185&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q44230185&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q44230185\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"> <a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/identities/containsVIAFID/35936284\">WorldCat Identities</a></span></li>\n<li><span class=\"nowrap\"><a href=\"/wiki/Library_of_Congress_Control_Number\" title=\"Library of Congress Control Number\">LCCN</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"http://id.loc.gov/authorities/names/n86085848\">n86085848</a></span></span></li>\n<li><span class=\"nowrap\"><a href=\"/wiki/Virtual_International_Authority_File\" title=\"Virtual International Authority File\">VIAF</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://viaf.org/viaf/35936284\">35936284</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1245\nCached time: 20180909222347\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.232 seconds\nReal time usage: 0.307 seconds\nPreprocessor visited node count: 1598/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 25503/2097152 bytes\nTemplate argument size: 1644/2097152 bytes\nHighest expansion depth: 11/40\nExpensive parser function count: 2/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 9853/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.114/10.000 seconds\nLua memory usage: 3.31 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  261.470      1 -total\n 48.92%  127.902      1 Template:Infobox_economist\n 46.72%  122.162      1 Template:Infobox_person\n 39.50%  103.280      2 Template:Infobox\n 35.67%   93.264      1 Template:Reflist\n 13.27%   34.693      1 Template:Authority_control\n 13.14%   34.355      1 Template:Cite_news\n 11.28%   29.492      5 Template:Cite_journal\n  5.01%   13.092      4 Template:Main_other\n  4.81%   12.577      5 Template:Br_separated_entries\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:55534101-0!canonical and timestamp 20180909222347 and revision id 825175475\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"Garrison, Louis Preston","hidden":"","*":"Pages_to_import_images_to_Wikidata"},{"sortkey":"Garrison, Louis Preston","hidden":"","*":"Articles_with_hCards"},{"sortkey":"Garrison, Louis Preston","hidden":"","*":"Wikipedia_articles_with_LCCN_identifiers"},{"sortkey":"Garrison, Louis Preston","hidden":"","*":"Wikipedia_articles_with_VIAF_identifiers"},{"sortkey":"Garrison, Louis Preston","*":"1950_births"},{"sortkey":"Garrison, Louis Preston","*":"Living_people"},{"sortkey":"Garrison, Louis Preston","*":"University_of_Washington_faculty"},{"sortkey":"Garrison, Louis Preston","*":"Indiana_University_alumni"},{"sortkey":"Garrison, Louis Preston","*":"Stanford_University_alumni"},{"sortkey":"Garrison, Louis Preston","*":"American_economists"},{"sortkey":"Garrison, Louis Preston","*":"Health_economists"}],"links":[{"ns":14,"exists":"","*":"Category:Wikipedia articles with LCCN identifiers"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with VIAF identifiers"},{"ns":0,"exists":"","*":"B.A."},{"ns":0,"exists":"","*":"Battelle Memorial Institute"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Emeritus"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Health economics"},{"ns":0,"exists":"","*":"Health economist"},{"ns":0,"exists":"","*":"Hoffmann-La Roche"},{"ns":0,"exists":"","*":"Indiana"},{"ns":0,"exists":"","*":"Indiana University"},{"ns":0,"exists":"","*":"Insurance"},{"ns":0,"exists":"","*":"Library of Congress Control Number"},{"ns":0,"exists":"","*":"News and Tribune"},{"ns":0,"exists":"","*":"Personalized medicine"},{"ns":0,"exists":"","*":"Ph.D."},{"ns":0,"exists":"","*":"PharmacoEconomics"},{"ns":0,"exists":"","*":"Pharmacoeconomics"},{"ns":0,"exists":"","*":"Pharmacogenomics"},{"ns":0,"exists":"","*":"Pricing"},{"ns":0,"exists":"","*":"Professor Emeritus"},{"ns":0,"exists":"","*":"Project HOPE"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Reimbursement"},{"ns":0,"exists":"","*":"Stanford University"},{"ns":0,"exists":"","*":"The American Journal of Managed Care"},{"ns":0,"exists":"","*":"Therapeutic Innovation & Regulatory Science"},{"ns":0,"exists":"","*":"United States of America"},{"ns":0,"exists":"","*":"University of Washington"},{"ns":0,"exists":"","*":"University of Washington School of Pharmacy"},{"ns":0,"exists":"","*":"Victor Fuchs"},{"ns":0,"exists":"","*":"Virtual International Authority File"},{"ns":0,"*":"MJ Finley Austin"},{"ns":0,"*":"Adrian Towse"},{"ns":12,"exists":"","*":"Help:Authority control"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox economist"},{"ns":10,"exists":"","*":"Template:Infobox person"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:Br separated entries"},{"ns":10,"exists":"","*":"Template:If empty"},{"ns":10,"exists":"","*":"Template:Unbulleted list"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:URL"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Wikidata image"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Separated entries"},{"ns":828,"exists":"","*":"Module:TableTools"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:If empty"},{"ns":828,"exists":"","*":"Module:List"},{"ns":828,"exists":"","*":"Module:URL"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"}],"images":["Garrison_portrait_1.png","Blue_pencil.svg"],"externallinks":["https://www.nytimes.com/2009/08/26/business/economy/26leonhardt.html","http://theoncologist.alphamedpress.org/content/15/suppl_1/49.short","//doi.org/10.1634/theoncologist.2010-S1-49","http://journals.sagepub.com/doi/abs/10.1177/009286150704100408","//doi.org/10.1177/009286150704100408","http://www.mdpi.com/2075-4426/7/3/10","//doi.org/10.3390/jpm7030010","https://link.springer.com/article/10.2165/00019053-200826070-00002","//www.ncbi.nlm.nih.gov/pubmed/18563946","http://www.ajmc.com/journals/issue/2015/2015-vol21-n9/Private-Sector-Risk-Sharing-Agreements-in-the-United-States-Trends-Barriers-and-Prospects","//www.ncbi.nlm.nih.gov/pubmed/26618366","http://www.pharmavoice.com/current-100/","http://www.newsandtribune.com/news/new-albany-high-school-hall-of-fame-class-announced/article_86c754e2-59f1-11e7-ac0f-27906ccb99f3.html","https://www.wikidata.org/wiki/Q44230185","https://sop.washington.edu/people/louis-garrison/","https://www.worldcat.org/identities/containsVIAFID/35936284","http://id.loc.gov/authorities/names/n86085848","https://viaf.org/viaf/35936284"],"sections":[{"toclevel":1,"level":"2","line":"Education","number":"1","index":"1","fromtitle":"Louis_Preston_Garrison","byteoffset":1918,"anchor":"Education"},{"toclevel":1,"level":"2","line":"Career","number":"2","index":"2","fromtitle":"Louis_Preston_Garrison","byteoffset":2432,"anchor":"Career"},{"toclevel":1,"level":"2","line":"Incentives to pharmaceutical innovation","number":"3","index":"3","fromtitle":"Louis_Preston_Garrison","byteoffset":3285,"anchor":"Incentives_to_pharmaceutical_innovation"},{"toclevel":1,"level":"2","line":"Value of personalized medicine","number":"4","index":"4","fromtitle":"Louis_Preston_Garrison","byteoffset":4509,"anchor":"Value_of_personalized_medicine"},{"toclevel":1,"level":"2","line":"Risk sharing agreements","number":"5","index":"5","fromtitle":"Louis_Preston_Garrison","byteoffset":6201,"anchor":"Risk_sharing_agreements"},{"toclevel":1,"level":"2","line":"Awards and recognition","number":"6","index":"6","fromtitle":"Louis_Preston_Garrison","byteoffset":8140,"anchor":"Awards_and_recognition"},{"toclevel":1,"level":"2","line":"Legacy","number":"7","index":"7","fromtitle":"Louis_Preston_Garrison","byteoffset":8973,"anchor":"Legacy"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"8","fromtitle":"Louis_Preston_Garrison","byteoffset":9352,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Louis Preston Garrison","iwlinks":[],"properties":[{"name":"defaultsort","*":"Garrison, Louis Preston"},{"name":"wikibase_item","*":"Q44230185"}]}}